These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Cervical carcinoma antigens in the diagnosis of human squamous cell carcinoma of the cervix. Haines HG, McCoy JP, Hofheinz DE, Ng AB, Nordqvist SR, Leif RC. J Natl Cancer Inst; 1981 Mar; 66(3):465-74. PubMed ID: 7009947 [Abstract] [Full Text] [Related]
24. Characterization of gamma-glutamyltranspeptidase in murine cervical cancer by biochemical and immunological techniques. Chen YF, Haskill S. Cancer Res; 1984 Oct; 44(10):4548-52. PubMed ID: 6205750 [Abstract] [Full Text] [Related]
26. An evaluation of herpes simplex virus antigenic markers in the study of established and developing cervical neoplasia. Smith CC, Aurelian L, Gupta PK, Frost JK, Rosenshein NB, Klacsmann K, Geddes S. Anal Quant Cytol; 1980 Jun; 2(2):131-43. PubMed ID: 6255843 [Abstract] [Full Text] [Related]
28. Prognostic significance of pretreatment squamous cell carcinoma antigen and carcinoembryonic antigen in squamous cell carcinoma of the uterine cervix. Bae SN, Namkoong SE, Jung JK, Kim CJ, Park JS, Kim JW, Lee JM, Kim SJ. Gynecol Oncol; 1997 Mar; 64(3):418-24. PubMed ID: 9062143 [Abstract] [Full Text] [Related]
34. Relationship of skin reactive intestinal cancer antigen to the carcinoembryonic antigen of Gold and other antigens. Herberman RB, Hollinshead AC, von Kleist S. Ann Immunol (Paris); 1973 Nov 14; 124(4):597-8. PubMed ID: 4134476 [No Abstract] [Full Text] [Related]
35. Herpesvirus type 2-induced, tumor-specific antigen in cervical carcinoma. Aurelian L, Davis HJ, Julian CG. Am J Epidemiol; 1973 Jul 14; 98(1):1-9. PubMed ID: 4131112 [No Abstract] [Full Text] [Related]
36. Identification, purification, and radioimmunoassay of NB/70K, a human ovarian tumor-associated antigen. Knauf S, Urbach GI. Cancer Res; 1981 Apr 14; 41(4):1351-7. PubMed ID: 6163521 [Abstract] [Full Text] [Related]
37. [Antigenic structures of CEA and CEA-related normal antigens and problems related to the determination of blood CEA concentrations]. Matsuoka Y, Kuroki M, Koga Y. Gan To Kagaku Ryoho; 1983 Feb 14; 10(2 Pt 2):575-84. PubMed ID: 6192762 [Abstract] [Full Text] [Related]
38. [Preparation and characterization of human colon tumor-associated antigen and its clinical significance]. Liu XY, Yao XL, Song Y, Liu XY, Zhang P, Xu ZS, Song LH. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Apr 14; 23(4):335-7. PubMed ID: 17428389 [Abstract] [Full Text] [Related]
39. [Tumor antigen TA-4 of squamous cell carcinoma in patients with cervical cancer]. Kato H, Morioka H, Aramaki S, Tamai K, Nagaya T, Nagai M, Torigoe T. Gan No Rinsho; 1984 May 14; 30(6 Suppl):574-7. PubMed ID: 6748228 [Abstract] [Full Text] [Related]
40. Partial purification of C-C36 tumor rejection antigen molecules commonly expressed on syngeneic murine colon tumors, C-C36 and C-C26. Sato N, Sato T, Takahashi S, Fujimoto N, Koshiba H, Ishii Y, Kikuchi K. Jpn J Cancer Res; 1986 May 14; 77(5):473-9. PubMed ID: 3089978 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]